biology-news-1/aware--inc--reports-second-quarter-2009-financial-results-9452-3/;msg90356

Breaking Biology Technology:Martek Signs Sole-Source Supply Agreement with Fonterra 2 Martek Signs Sole-Source Supply Agreement with Fonterra 3 La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2 La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3 MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4

[0] Martek Signs Sole-Source Supply Agreement with Fonterra [0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain [0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products

Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7 China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4 Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 1 Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 2 Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 3 Beetroot Juice May Boost Stamina 53957 1 Beetroot Juice May Boost Stamina 53957 2 Insulet Corporation to Present at Upcoming Investor Conferences 53953 1 Insulet Corporation to Present at Upcoming Investor Conferences 53953 2

[0] China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 [0] OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months [0] Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation